Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) Read more about Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) US Application 61/568,590Filed on 2011-12-08
Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) Read more about Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) US Application 61/792,081Filed on 2013-03-15
Recurrent Mutation In Mitogen-Activated Protein Kinase Kinase Kinase 5 (MAP3K5) For Diagnosing And Treating Melanoma Read more about Recurrent Mutation In Mitogen-Activated Protein Kinase Kinase Kinase 5 (MAP3K5) For Diagnosing And Treating Melanoma US Application 61/708,785Filed on 2012-10-02
Silent Mutation In Bcl-2-Like Protein 12 (BCL2L12) For Diagnosing and Treating Melanoma Read more about Silent Mutation In Bcl-2-Like Protein 12 (BCL2L12) For Diagnosing and Treating Melanoma US Application 61/673,454Filed on 2012-07-19
Encapsulated N-acetyl-mannosamine (ManNAc) And N-acetylneuraminic Acid (NANA Or Neu5Ac) To Increase Sialylation Read more about Encapsulated N-acetyl-mannosamine (ManNAc) And N-acetylneuraminic Acid (NANA Or Neu5Ac) To Increase Sialylation US Application 61/531,934Filed on 2011-09-07
Anti-Cancer Therapy Sensitivity-Related ATAD5 Activity and Products and Methods Related Thereto Read more about Anti-Cancer Therapy Sensitivity-Related ATAD5 Activity and Products and Methods Related Thereto US Application 61/515,773Filed on 2011-08-05
ACSF3 Mutations in Metabolic Disorders7/1/2012 Read more about ACSF3 Mutations in Metabolic Disorders7/1/2012 US Application 61/504,030Filed on 2011-07-01
METHODS FOR DETECTING ADHD SUSCEPTIBILITY AND PREDICTING SEVERITY AND LONG TERM OUTCOME OF ADHD SYMPTOMS Read more about METHODS FOR DETECTING ADHD SUSCEPTIBILITY AND PREDICTING SEVERITY AND LONG TERM OUTCOME OF ADHD SYMPTOMS US Application 61/505,864Filed on 2011-07-08
Method of Treating Pathologic Heterotopic Ossification (HO) Read more about Method of Treating Pathologic Heterotopic Ossification (HO) US Application 61/504,041Filed on 2011-07-01
Methods for Treating Leukemia And Disorders Mediated By CBFB AND RUNX1 Proteins Read more about Methods for Treating Leukemia And Disorders Mediated By CBFB AND RUNX1 Proteins US Application 61/453,863Filed on 2011-03-17